In contrast to our study Thomadaki et al., (2012).noticed that Leukemia patients expressing high level of BCL2L12 were 3 times more likely to relapse (p=0.004) or die (p=0.007) than patients with low level of BCL2L12 expression. This evidence concerns the gene BCL2L12 and leukemia.